$NAUT News
Last published 2w ago
- 2w agoNAUTNautilus Biotechnology Q3 2026 earnings Call - NAUTILUS BIOTECHNOLOGY INCEarnings Call TranscriptsGood day and thank you for standing by. Welcome to Nautilus Biotechnology Q3 2026 earnings call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and an
- 2w agoNAUTNautilus Biotechnology Reports Third Quarter 2026 Financial ResultsGlobeNewswireSEATTLE, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended
- 2w agoNAUTNautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS ConsortiumGlobeNewswireSEATTLE, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT), a company pioneering intact, single-molecule proteomics approaches, today announced its participation in SEEDS
- 2w agoNAUTNautilus Biotechnology, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 3w agoNAUTNautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026GlobeNewswireSEATTLE, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced it will report financial
- 2mo agoNAUTNature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau ProteoformsGlobeNewswireKey takeaways: Going beyond measurement of bulk tau to quantify each of the diverse proteoforms of tau is key to developing novel diagnostics and precision medicine for Alzheimer’s disease and related
- 3mo agoNAUTNautilus Biotechnology Reports Second Quarter 2026 Financial ResultsGlobeNewswireSEATTLE, July 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended
- 4mo agoNAUTNautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026GlobeNewswireSEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced it will report financial
- 6mo agoNAUTNautilus Biotechnology Reports First Quarter 2026 Financial ResultsGlobeNewswireSEATTLE, April 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended
- 7mo agoNAUTNautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026GlobeNewswireSEATTLE, April 09, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results
- 7mo agoNAUTNautilus Biotechnology to Participate in the Investor Summit Group Virtual ConferenceGlobeNewswireSEATTLE, March 24, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced the company will be
- 8mo agoNAUTNautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of SalesGlobeNewswireSEATTLE, March 02, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT), a company pioneering single-molecule proteome analysis, today announced the appointment of Amber Faust as Vice President of
- 8mo agoNAUTNautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial ResultsGlobeNewswireSEATTLE, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the fourth quarter and
- 8mo agoNAUTNautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026GlobeNewswire• Revealed core proteomics instrument during US HUPO 2026 following successful field evaluation at the Buck Institute for Research on Aging • Commercial launch expected to initiate in late 2026, marking a major milestone
- 8mo agoNAUTNautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care ConferenceGlobeNewswireSEATTLE, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating
- 9mo agoNAUTNautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026GlobeNewswireSEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results
- 9mo agoNAUTNautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson's DiseaseGlobeNewswire• Support from The Michael J. Fox Foundation for Parkinson's Research to advance critical research into Parkinson's disease biology • Nautilus' development of a single-molecule assay for measuring alpha-synuclein
- 10mo agoNAUTNautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms AssayGlobeNewswireSEATTLE, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering single-molecule proteome analysis, today announced the launch of an Early Access Program for
- 1y agoNAUTNautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on AgingGlobeNewswire• Buck Institute's deployment of Nautilus' instrument generates tau proteoform data, providing external validation of the company's next-generation single-molecule proteomics platform • Joint research results show high
- 1y agoNAUTNautilus Q3 2025 Earnings Conference Call - NAUTILUS BIOTECHNOLOGY INCEarnings Call TranscriptsGood day, and thank you for standing by. Welcome to the Nautilus Biotechnology 3rd Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there
- 1y agoNAUTNautilus Biotechnology Reports Third Quarter 2025 Financial ResultsGlobeNewswireSEATTLE, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third
- 1y agoNAUTNautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025GlobeNewswireSEATTLE, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results
- 1y agoNAUTNautilus Biotechnology, Inc. (NAUT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
- 1y agoNAUTNautilus Biotechnology to Participate in Upcoming September Investor ConferencesGlobeNewswireSEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating
- 1y agoNAUTNautilus Biotechnology, Inc. (NAUT) Q2 2025 Earnings Conference Call TranscriptEarnings Call Transcripts
- 1y agoNAUTNautilus Biotechnology Reports Second Quarter 2025 Financial ResultsGlobeNewswireSEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second
- 1y agoNAUTNautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule ProteomicsGlobeNewswire• Allen Institute to employ Iterative Mapping, Nautilus' single-molecule proteomics method, to investigate connection between tau protein and Alzheimer's disease • Agreement links the organizations' next-generation
- 1y agoNAUTNautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025GlobeNewswireSEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it
- 1y agoNAUTNautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare ConferenceGlobeNewswireSEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the
- 1y agoNAUTNautilus Biotechnology Reports First Quarter 2025 Financial ResultsGlobeNewswireSEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first
- 1y agoNAUTNautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025GlobeNewswireSEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial
- 1y agoNAUTNautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial ResultsGlobeNewswireSEATTLE, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the fourth
- 1y agoNAUTNautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare ConferenceGlobeNewswireSEATTLE, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the
- 1y agoNAUTNautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025GlobeNewswireSEATTLE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single molecule protein analysis platform, today announced it will report financial results
- 2y agoNAUTNautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator AwardGlobeNewswireSEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced
- 2y agoNAUTNautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare ConferenceGlobeNewswireSEATTLE, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating
- 2y agoNAUTNautilus Biotechnology, Inc. (NAUT) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNAUTNautilus Biotechnology Reports Third Quarter 2024 Financial ResultsGlobeNewswireSEATTLE, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third
- 2y agoNAUTNautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024GlobeNewswireSEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single molecule protein analysis platform, today announced it will report financial results
- 2y agoNAUTNautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing OfficerGlobeNewswireSEATTLE, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform for comprehensively quantifying the proteome,
- 2y agoNAUTNautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceGlobeNewswireSEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule proteome analysis platform, today announced the company will participate in
- 2y agoNAUTNautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNAUTNautilus Biotechnology Reports Second Quarter 2024 Financial ResultsGlobeNewswireSEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second
- 2y agoNAUTNautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024GlobeNewswireSEATTLE, July 09, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single molecule protein analysis platform, today announced it will report financial results
- 2y agoNAUTNautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceGlobeNewswireSEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating
- 2y agoNAUTNautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNAUTNautilus Biotechnology Reports First Quarter 2024 Financial ResultsGlobeNewswireSEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single molecule proteome analysis platform, today reported financial results for the first
- 2y agoNAUTNautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024GlobeNewswireSEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single molecule protein analysis platform, today announced it will report financial results
- 2y agoNAUTNautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNAUTNautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsGlobeNewswireSEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single molecule proteome analysis platform, today reported financial results for the fourth